Advertisement
BCRX or CASI or XNCR
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BCRX’s FA Score shows that 0 FA rating(s) are green whileCASI’s FA Score has 0 green FA rating(s), and XNCR’s FA Score reflects 0 green FA rating(s).
- BCRX’s FA Score: 0 green, 5 red.
- CASI’s FA Score: 0 green, 5 red.
- XNCR’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BCRX’s TA Score shows that 4 TA indicator(s) are bullish while CASI’s TA Score has 6 bullish TA indicator(s), and XNCR’s TA Score reflects 3 bullish TA indicator(s).
- BCRX’s TA Score: 4 bullish, 5 bearish.
- CASI’s TA Score: 6 bullish, 2 bearish.
- XNCR’s TA Score: 3 bullish, 6 bearish.
Price Growth
BCRX (@Biotechnology) experienced а -0.80% price change this week, while CASI (@Biotechnology) price change was -7.47% , and XNCR (@Biotechnology) price fluctuated +2.06% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +2.69%. For the same industry, the average monthly price growth was +18.51%, and the average quarterly price growth was +31.06%.
Reported Earning Dates
BCRX is expected to report earnings on Oct 29, 2025.
CASI is expected to report earnings on May 16, 2025.
XNCR is expected to report earnings on Nov 10, 2025.
Industries' Descriptions
@Biotechnology (+2.69% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
| BCRX | CASI | XNCR | |
| Capitalization | 1.83B | 20.1M | 601M |
| EBITDA | 47.6M | -38.42M | -161.68M |
| Gain YTD | 15.957 | -54.064 | -63.272 |
| P/E Ratio | N/A | N/A | N/A |
| Revenue | 503M | 31.4M | 127M |
| Total Cash | 295M | 12.7M | 470M |
| Total Debt | 795M | 18.5M | 67.8M |
BCRX | CASI | XNCR | ||
|---|---|---|---|---|
OUTLOOK RATING 1..100 | 53 | 30 | 4 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 50 Fair valued | 50 Fair valued | 50 Fair valued | |
PROFIT vs RISK RATING 1..100 | 74 | 100 | 100 | |
SMR RATING 1..100 | 100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 51 | 94 | 89 | |
P/E GROWTH RATING 1..100 | 100 | 100 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 33 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BCRX's Valuation (50) in the Biotechnology industry is in the same range as CASI (50) and is in the same range as XNCR (50). This means that BCRX's stock grew similarly to CASI’s and similarly to XNCR’s over the last 12 months.
BCRX's Profit vs Risk Rating (74) in the Biotechnology industry is in the same range as CASI (100) and is in the same range as XNCR (100). This means that BCRX's stock grew similarly to CASI’s and similarly to XNCR’s over the last 12 months.
BCRX's SMR Rating (100) in the Biotechnology industry is in the same range as CASI (100) and is in the same range as XNCR (100). This means that BCRX's stock grew similarly to CASI’s and similarly to XNCR’s over the last 12 months.
BCRX's Price Growth Rating (51) in the Biotechnology industry is somewhat better than the same rating for XNCR (89) and is somewhat better than the same rating for CASI (94). This means that BCRX's stock grew somewhat faster than XNCR’s and somewhat faster than CASI’s over the last 12 months.
BCRX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as XNCR (100) and is in the same range as CASI (100). This means that BCRX's stock grew similarly to XNCR’s and similarly to CASI’s over the last 12 months.
| BCRX | CASI | XNCR | |
|---|---|---|---|
| RSI ODDS (%) | 1 day ago 90% | 1 day ago 80% | N/A |
| Stochastic ODDS (%) | 1 day ago 83% | 1 day ago 90% | 1 day ago 87% |
| Momentum ODDS (%) | 1 day ago 86% | 1 day ago 78% | 1 day ago 66% |
| MACD ODDS (%) | N/A | 1 day ago 74% | 1 day ago 71% |
| TrendWeek ODDS (%) | 1 day ago 80% | 1 day ago 90% | 1 day ago 74% |
| TrendMonth ODDS (%) | 1 day ago 82% | 1 day ago 90% | 1 day ago 84% |
| Advances ODDS (%) | 7 days ago 79% | 6 days ago 82% | 7 days ago 71% |
| Declines ODDS (%) | 5 days ago 79% | 16 days ago 90% | 5 days ago 80% |
| BollingerBands ODDS (%) | 1 day ago 77% | 1 day ago 86% | 1 day ago 82% |
| Aroon ODDS (%) | 1 day ago 84% | 1 day ago 82% | 1 day ago 82% |
Advertisement
BCRX and
Correlation & Price change
A.I.dvisor indicates that over the last year, BCRX has been loosely correlated with VCYT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if BCRX jumps, then VCYT could also see price increases.
| Ticker / NAME | Correlation To BCRX | 1D Price Change % | ||
|---|---|---|---|---|
| BCRX | 100% | -2.68% | ||
| VCYT - BCRX | 46% Loosely correlated | -5.29% | ||
| CRNX - BCRX | 41% Loosely correlated | -3.60% | ||
| HOWL - BCRX | 39% Loosely correlated | +1.55% | ||
| ETNB - BCRX | 39% Loosely correlated | -5.49% | ||
| BEAM - BCRX | 39% Loosely correlated | -7.51% | ||
More | ||||
CASI and
Correlation & Price change
A.I.dvisor tells us that CASI and ASND have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CASI and ASND's prices will move in lockstep.
| Ticker / NAME | Correlation To CASI | 1D Price Change % | ||
|---|---|---|---|---|
| CASI | 100% | -9.09% | ||
| ASND - CASI | 33% Poorly correlated | -0.08% | ||
| ADCT - CASI | 29% Poorly correlated | -2.99% | ||
| RIGL - CASI | 29% Poorly correlated | -2.33% | ||
| SRPT - CASI | 28% Poorly correlated | -5.30% | ||
| IOVA - CASI | 26% Poorly correlated | -3.48% | ||
More | ||||
XNCR and
Correlation & Price change
A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with CRNX. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then CRNX could also see price increases.
| Ticker / NAME | Correlation To XNCR | 1D Price Change % | ||
|---|---|---|---|---|
| XNCR | 100% | -4.63% | ||
| CRNX - XNCR | 59% Loosely correlated | -3.60% | ||
| BEAM - XNCR | 56% Loosely correlated | -7.51% | ||
| SYRE - XNCR | 56% Loosely correlated | -6.70% | ||
| KRYS - XNCR | 55% Loosely correlated | -1.78% | ||
| IDYA - XNCR | 54% Loosely correlated | -5.09% | ||
More | ||||